Potential resurgence of respiratory syncytial virus in Canada
- PMID: 34312169
- PMCID: PMC8321303
- DOI: 10.1503/cmaj.210919
Potential resurgence of respiratory syncytial virus in Canada
Conflict of interest statement
Competing interests: Pascal Lavoie and Alfonso Solimano serve on the Executive Committee, and Alfonso Solimano is the Medical Director, of the British Columbia Respiratory Syncytial Virus (RSV) Immunoprophylaxis Program, a publicly funded program under the British Columbia Ministry of Health’s Provincial Health Services Authority. Joanne Langley’s study site has done research studies on RSV vaccines with GSK, Janssen and Pfizer. Funding for these studies is paid to Dalhousie University. No other competing interests were declared.
References
-
- Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. . Respiratory syncytial virus seasonality: a global overview. J Infect Dis 2018;217:1356–64. - PubMed
-
- Respiratory virus detections in Canada. Ottawa: Public Health Agency of Canada; 2021. Available: https://www.canada.ca/en/public-health/services/surveillance/respiratory... (accessed 2021 May 12).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical